Evidence map›Paper›PMID 27923387›Full record

ArticleBreast cancer research : BCR2016

Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.

Serghei Malkov, John A Shepherd, Christopher G Scott, Rulla M Tamimi, Lin Ma, Kimberly A Bertrand, Fergus Couch, Matthew R Jensen, Amir P Mahmoudzadeh, Bo Fan and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Imaging for local recurrence of breast cancer.Journal of cancer research and clinical oncology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Serghei MalkovDepartment of Radiology and Biomedical Imaging, UCSF School of Medicine, San Francisco, CA, USA. serghei.malkov@ucsf.edu.ORCID 0000-0003-0548-6022
John A ShepherdDepartment of Radiology and Biomedical Imaging, UCSF School of Medicine, San Francisco, CA, USA.
Christopher G ScottMayo Clinic, Rochester, MN, USA.
Rulla M TamimiHarvard Medical School, Boston, MA, USA.
Lin MaUCSF Departments of Medicine and Epidemiology/Biostatistics, San Francisco, CA, USA.
Kimberly A BertrandSlone Epidemiology Center at Boston University, Boston, MA, USA.
Fergus CouchMayo Clinic, Rochester, MN, USA.
Matthew R JensenMayo Clinic, Rochester, MN, USA.
Amir P MahmoudzadehDepartment of Radiology and Biomedical Imaging, UCSF School of Medicine, San Francisco, CA, USA.
Bo FanDepartment of Radiology and Biomedical Imaging, UCSF School of Medicine, San Francisco, CA, USA.
Aaron NormanMayo Clinic, Rochester, MN, USA.
Kathleen R BrandtMayo Clinic, Rochester, MN, USA.
V Shane PankratzMayo Clinic, Rochester, MN, USA.
Celine M VachonMayo Clinic, Rochester, MN, USA.
Karla KerlikowskeUCSF Departments of Medicine and Epidemiology/Biostatistics, San Francisco, CA, USA.
Mayo Clinic in Arizona · USUniversity of California, San Francisco · USBoston University · USHarvard University · US

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2005 to 2026
$49.9M
Tissue and Outcomes CoreP50CA058207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLACKBURN, ELIZABETH H · 1992 to 2012
$32.7M
Risk Factors for Breast Cancer in Younger NursesR01CA050385 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 1989 to 2019
$32.3M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
San Francisco Mammography Registry-A Research SourceU01CA063740 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KERLIKOWSKE, KARLA M · 1994 to 2011
$6.2M
Identifying and validating novel susceptibility genes for breast cancerR01CA176785 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH, NATHANSON, KATHERINE L. · 2014 to 2018
$3.4M
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer DiagnosisR01CA166945 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GIGER, MARYELLEN L., SHEPHERD, JOHN ALAN · 2013 to 2017
$3.3M
A Mayo Cohort Study of Mammographic Breast DensityR01CA097396 · NCI · MAYO CLINIC ROCHESTER · PI VACHON, CELINE M · 2003 to 2007
$3.1M
BRCA2 missense mutations and breast cancerR01CA116167 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2007 to 2011
$3.0M
NCI NIH HHS P01 CA087969NCI NIH HHS P01 CA154292NCI NIH HHS P50 CA058207NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA050385NCI NIH HHS R01 CA097396NCI NIH HHS R01 CA116167NCI NIH HHS R01 CA124865NCI NIH HHS R01 CA128931NCI NIH HHS R01 CA131332NCI NIH HHS R01 CA140286NCI NIH HHS R01 CA166945NCI NIH HHS R01 CA175080NCI NIH HHS R21 CA157254NCI NIH HHS U01 CA063740NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA186107
6 · The paper itself

Abstract

backgroundSeveral studies have shown that mammographic texture features are associated with breast cancer risk independent of the contribution of breast density. Thus, texture features may provide novel information for risk stratification. We examined the association of a set of established texture features with breast cancer risk by tumor type and estrogen receptor (ER) status, accounting for breast density.

methodsThis study combines five case-control studies including 1171 breast cancer cases and 1659 controls matched for age, date of mammogram, and study. Mammographic breast density and 46 breast texture features, including first- and second-order features, Fourier transform, and fractal dimension analysis, were evaluated from digitized film-screen mammograms. Logistic regression models evaluated each normalized feature with breast cancer after adjustment for age, body mass index, first-degree family history, percent density, and study.

resultsOf the mammographic features analyzed, fractal dimension and second-order statistics features were significantly associated (p < 0.05) with breast cancer. Fractal dimensions for the thresholds equal to 10% and 15% (FD_TH_10 [corrected] and FD_TH_15) [corrected] were associated with an increased risk of breast cancer while thresholds from 60% to 85% (FD_TH_60 to FD_TH_85) [corrected] were associated with a decreased risk. Increasing the FD_TH_75 [corrected] and Energy feature values were associated with a decreased risk of breast cancer while increasing Entropy was associated with an increased [corrected] risk of breast cancer. For example, 1 standard deviation increase of FD_TH_75 [corrected] was associated with a 13% reduced risk of breast cancer (odds ratio = 0.87, 95% confidence interval 0.79-0.95). Overall, the direction of associations between features and ductal carcinoma in situ (DCIS) and invasive cancer, and estrogen receptor positive and negative cancer were similar.

conclusionMammographic features derived from film-screen mammograms are associated with breast cancer risk independent of percent mammographic density. Some texture features also demonstrated associations for specific tumor types. For future work, we plan to assess risk prediction combining mammographic density and features assessed on digital images.

Indexed as

Breast DensityAgedBody Mass IndexBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCase-Control StudiesFemaleFractalsHumansLogistic ModelsMammographyMass ScreeningMiddle AgedReceptors, EstrogenRisk AssessmentRisk FactorsReceptors, Estrogen

Identifiers

PMID27923387
PMCPMC5139106
OpenAlexW2560286078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.